Search results
Nov 28, 2023 · Background. In a randomized trial, Lianhuaqingwen (LHQW) capsule was effective for accelerating symptom recovery among patients with coronavirus disease 2019 (COVID-19). However, the lack of blinding and limited sample sizes decreased the level of clinical evidence.
Lianhua Qingwen (simplified Chinese: 连花清瘟; traditional Chinese: 連花清瘟; lit. 'medicine using Forsythia suspensa and Lonicera japonica to clear illness', [1] LHQW) is a traditional Chinese medicine (TCM) formulation used for the treatment of influenza. [2]
Jan 27, 2022 · Objectives: Lianhua Qingwen capsule/granule (LHQW) is an innovative patented traditional Chinese medicine with potential curative effects on respiratory diseases. However, no consensus has been reached on the security of LHQW to date.
Previous studies reported that Lianhua Qingwen might have positive effects, including broad-spectrum antiviral, cough and expectorant, antipyretic and anti-inflammatory, immune-regulating, effective antibacterial and other systemic intervention functions (Liu et al., 2010; Liu 2015; Wang, et al., 2015).
May 16, 2020 · Lianhuaqingwen (LH) capsule, a repurposed marketed Chinese herb product, has been proven effective for influenza. Purpose. To determine the safety and efficacy of LH capsule in patients with Covid-19. Methods. We did a prospective multicenter open-label randomized controlled trial on LH capsule in confirmed cases with Covid-19.
Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial. Jin-ping Zheng, Yun Ling, +17 authors. Nan-shan Zhong. Published in Virology Journal 28 November 2023. Medicine. TLDR.
May 5, 2023 · Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial.
